$CURR announced the allowance of Chinese Patent No
Post# of 23607
![Avatar](/images/ProfileImages/734810790_1098_wst.png)
“Securing this key patent supports our global commercialization strategy for CUREfilm Blue as well as follow-on drugs delivered using thin film,” said Rob Davidson, CEO of CURE Pharmaceutical. “We are focused on the Asian market for this first product, and in particular China, a high-demand ED drug market where consumers are early adopters of innovative dosage forms.”
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)